Silencing of MiR-23a Attenuates Hydrogen Peroxide (HO) Induced Oxidative Damages in ARPE-19 Cells by Upregulating GLS1: an in Vitro Study
Overview
Genetics
Authors
Affiliations
Background: Oxidative damages contributes to age-related macular degeneration (AMD) caused vision blindness, but the molecular mechanisms are still largely unknown.
Objectives: This study managed to investigate this issue by conducting in vitro experiments.
Methods: Oxidative stress were evaluated by L-012 dye, DHE staining and MDA assay. CCK-8 and colony formation assay were conducted to examine cell proliferation. Cell death was evaluated by trypan blue staining and Annexin V-FITC/PI double staining method through flow cytometry (FCM). The binding sites of miR-23a and GLS1 mRNA were predicted by online miRDB database and validated by dual-luciferase reporter gene system. Real-Time qPCR for miR-23a levels and Western Blot for protein expressions.
Results: The retinal pigment epithelial (RPE) cells (ARPE-19) were subjected to hydrogen peroxide (HO) stimulation to simulate AMD progression in vitro, and we identified a novel miR-23a/glutaminase-1 (GLS1) pathway that regulated HO induced oxidative damages in ARPE-19 cells. Mechanistically, HO induced oxidative stress, inhibited cell proliferation and induced cell death in ARPE-19 cells in a dose- and time-dependent manner. Also, HO stimulation hindered cell invasion, migration and glutamine uptake in ARPE-19 cells. Interestingly, we proved that HO increased miR-23a levels, while downregulated glutaminase-1 (GLS1) in ARPE-19 cells, and miR-23a targeted 3' untranslated region (3'UTR) of GLS1 mRNA for GLS1 degradation. Finally, our data suggested that silencing miR-23a upregulated GLS1 to reverse the detrimental effects of HO treatment on ARPE-19 cells.
Conclusions: In general, analysis of the data suggested that miR-23a ablation upregulated GLS1 to attenuate HO stimulation induced oxidative damages in ARPE-19 cells in vitro, and this study broadened our knowledge in this field, which might help to provide novel theranostic signatures for AMD.
Differentially expressed microRNAs targeting genes in key pathways in keratoconus.
Nowak-Malczewska D, Swierkowska J, Gajecka M Front Genet. 2024; 15:1301676.
PMID: 38469119 PMC: 10925626. DOI: 10.3389/fgene.2024.1301676.
Liu F, Gao H, Chen M, Li A, Liu T Biochem Genet. 2022; 60(6):2087-2105.
PMID: 35239092 DOI: 10.1007/s10528-022-10198-4.